NO762661L - - Google Patents

Info

Publication number
NO762661L
NO762661L NO762661A NO762661A NO762661L NO 762661 L NO762661 L NO 762661L NO 762661 A NO762661 A NO 762661A NO 762661 A NO762661 A NO 762661A NO 762661 L NO762661 L NO 762661L
Authority
NO
Norway
Prior art keywords
het
formula
lower alkyl
sulfur
ring
Prior art date
Application number
NO762661A
Other languages
English (en)
Norwegian (no)
Inventor
G J Durant
G S Sach
C R Ganellin
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of NO762661L publication Critical patent/NO762661L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO762661A 1975-07-31 1976-07-30 NO762661L (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31970/75A GB1564502A (en) 1975-07-31 1975-07-31 Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives

Publications (1)

Publication Number Publication Date
NO762661L true NO762661L (es) 1977-02-01

Family

ID=10331105

Family Applications (1)

Application Number Title Priority Date Filing Date
NO762661A NO762661L (es) 1975-07-31 1976-07-30

Country Status (31)

Country Link
US (4) US4083983A (es)
JP (2) JPS5219671A (es)
AR (1) AR213736A1 (es)
AT (1) AT356132B (es)
AU (1) AU502752B2 (es)
BE (1) BE844504A (es)
BG (1) BG27368A3 (es)
CA (1) CA1068711A (es)
CH (1) CH624938A5 (es)
CS (1) CS189018B2 (es)
DD (1) DD125204A5 (es)
DE (1) DE2634433A1 (es)
DK (1) DK316176A (es)
ES (1) ES450310A1 (es)
FI (1) FI762193A (es)
FR (1) FR2319343A1 (es)
GB (1) GB1564502A (es)
GR (1) GR60810B (es)
HU (1) HU173778B (es)
IE (1) IE43508B1 (es)
IL (1) IL50005A (es)
LU (1) LU75507A1 (es)
NL (1) NL7608496A (es)
NO (1) NO762661L (es)
PH (1) PH14555A (es)
PL (1) PL103684B1 (es)
PT (1) PT65348B (es)
SE (1) SE7608477L (es)
SU (1) SU692558A3 (es)
ZA (1) ZA764082B (es)
ZM (1) ZM9876A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4928863A (es) * 1972-07-13 1974-03-14
JPS5078968U (es) * 1973-11-20 1975-07-08
ZA774220B (en) * 1976-07-28 1978-06-28 Smith Kline French Lab Pharmacologically active compounds
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
US4282363A (en) * 1978-11-24 1981-08-04 Bristol-Myers Company 1-Nitro-2-(2-alkynylamino)-2-[(2-pyridylmethylthio)-ethylamino]ethylene derivatives
US4250316A (en) * 1978-11-24 1981-02-10 Bristol-Myers Company Pyridyl guanidine anti-ulcer agents
NL8000869A (nl) * 1979-02-16 1980-08-19 Eisai Co Ltd Cyanoguanidine-derivaten en werkwijze voor de bereiding daarvan.
PT74865B (en) * 1981-05-27 1983-12-07 Smithkline Beckman Corp Process of preparing a 2-(pyridylbutylamino)-pyrimidone and of its pharmaceutically acceptable salts
SE8204879D0 (sv) * 1982-08-26 1982-08-26 Haessle Ab Novel chemical intermediates
DE3232462A1 (de) * 1982-09-01 1984-03-01 Bayer Ag, 5090 Leverkusen 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPH0828166B2 (ja) * 1985-01-16 1996-03-21 松下電器産業株式会社 サ−モスタツト
AU660132B2 (en) * 1992-12-21 1995-06-08 Bayer Aktiengesellschaft Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridine
US5380734A (en) * 1993-04-15 1995-01-10 American Home Products Corporation N-cyanoamidine derivatives as anti-influenza agents
EP3813900A4 (en) 2018-06-29 2022-05-04 410 Medical, Inc. SYSTEMS, DEVICE AND METHOD FOR FILTERING AIR FROM A FLUID LINE
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
US3808336A (en) 1970-06-25 1974-04-30 Smithkline Corp Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3908014A (en) * 1970-06-25 1975-09-23 Smith Kline French Lab Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3905984A (en) * 1971-03-09 1975-09-16 Smith Kline French Lab Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
US4002759A (en) * 1973-05-17 1977-01-11 Smith Kline & French Laboratories Limited Pyridylbutylamino ethylene compounds
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4025527A (en) * 1973-07-13 1977-05-24 Smith Kline & French Laboratories Limited Certain thiazoles and oxazoles
GB1497260A (en) * 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives

Also Published As

Publication number Publication date
US4215126A (en) 1980-07-29
BE844504A (fr) 1977-01-24
CS189018B2 (en) 1979-03-30
JPS617423B2 (es) 1986-03-06
US4264608A (en) 1981-04-28
SE7608477L (sv) 1977-02-01
FR2319343A1 (fr) 1977-02-25
DE2634433A1 (de) 1977-02-03
JPS5219671A (en) 1977-02-15
PH14555A (en) 1981-09-24
IL50005A0 (en) 1976-09-30
NL7608496A (nl) 1977-02-02
LU75507A1 (es) 1977-03-03
AT356132B (de) 1980-04-10
CH624938A5 (es) 1981-08-31
ZA764082B (en) 1977-06-29
DD125204A5 (es) 1977-04-06
AU502752B2 (en) 1979-08-09
GB1564502A (en) 1980-04-10
IL50005A (en) 1981-06-29
FR2319343B1 (es) 1978-11-17
ES450310A1 (es) 1977-12-01
JPS60243069A (ja) 1985-12-03
GR60810B (en) 1978-08-30
BG27368A3 (en) 1979-10-12
AR213736A1 (es) 1979-03-15
ZM9876A1 (en) 1977-09-21
PL103684B1 (pl) 1979-07-31
PT65348A (en) 1976-08-01
PT65348B (en) 1978-01-06
DK316176A (da) 1977-02-01
US4426526A (en) 1984-01-17
ATA552576A (de) 1979-09-15
FI762193A (es) 1977-02-01
US4083983A (en) 1978-04-11
AU1645376A (en) 1978-02-02
IE43508L (en) 1977-01-31
IE43508B1 (en) 1981-03-11
HU173778B (hu) 1979-08-28
CA1068711A (en) 1979-12-25
SU692558A3 (ru) 1979-10-15

Similar Documents

Publication Publication Date Title
NO762661L (es)
US4013678A (en) Process for preparing heterocyclicalkylthioalkyl-n-cyanoguanidines
DK1797037T3 (en) PROCESS FOR THE PREPARATION OF 4- {4 - [({[4-chloro-3- (trifluoromethyl) phenyl] AMINO} CARBONYL) AMINO] PHENYOXY} N-methylpyridine-2-carboxamide
NO120426B (es)
FI63573C (fi) Foerfarande foer framstaellning av oxibensotiazin-dioxiders kaboxamider
NO145236B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive omega-aminocarboxylsyrederivater
IL33292A (en) Amino and imino derivatives of thiazolines,thiazolidines and thiazines,their preparation and pharmaceutical compositions containing them
NO764039L (es)
Zinnes et al. 1, 2-Benzothiazines. 6. 3-Carbamoyl-4-hydroxy-2H-1, 2-benzothiazine 1, 1-dioxides as antiinflammatory agents
NO151348B (no) Trikot stroempebukse og fremgangsmaate for fremstilling av samme
NO762659L (es)
NO770161L (no) Tiazolidinderivater og fremgangsm}te til deres fremstilling.
US4093621A (en) Process for preparing heterocyclicalkylthioalkyl-N-cyanoguanidines and thioureas
EP1042292A1 (en) Method for producing isoureas
JP3413632B2 (ja) グアニジン誘導体の製造方法
JPH0449539B2 (es)
WO2022206742A1 (zh) 一种一步法合成乙内酰硫脲衍生物的方法
NO803160L (no) Pyrimidin-derivater.
NO784350L (no) Fremgangsmaate til alkylering av 4(5)-merkaptometyl-imidazoler med aziridinderivater
US4226799A (en) α-Aminomethylene-β-formylaminopropionitrile and its manufacture
SU1227111A3 (ru) Способ получени производных гуанидина или их таутомерных соединений или их солей
NO148556B (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive triazinoner.
SU449485A3 (ru) Способ получени -замещенных сложных эфиров 1,2,3,6-тетрагидро-4пиридилметилкарбоновой кислоты
NO131345B (es)
CS203932B2 (en) Process for prepating new derivatives of thiazoline